Fourth European stroke science workshop
S Debette,D Strbian,JM Wardlaw,HB van der Worp,GJE Rinkel,V Caso,M Dichgans,E Tournier-Lasserve,C Grefkes,PJ Kelly,K Muir,E Berge,DA Trégouët,C Roffe,M Brainin,J Beck,T Steiner,LM de Lau,E Jouvent,R Veltkamp,JC Baron,K Nedeltchev,PM Bath,TJ Quinn,E Richard,U Ziemann,A Liesz,G Ntaios,C Iadecola,KR Lees,H Krarup Christensen,SJ van Veluw,M Endres,CS Anderson,CA Molina,M Düring,C Dufouil,L Ostergaard,NJ Samani,U Fischer,FE de Leeuw,B Norrving,GJ Biessels,C Cordonnier,JL Mas,H Mattle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DOI: https://doi.org/10.1177/2396987318774443
IF: 6.1
2018-05-24
European Stroke Journal
Abstract:Lake Eibsee, Garmisch-Partenkirchen, 16 to 18 November, 2017: The European Stroke Organisation convened >120 stroke experts from 21 countries to discuss latest results and hot topics in clinical, translational and basic stroke research. Since its inception in 2011, the European Stroke Science Workshop has become a cornerstone of European Stroke Organisation’s academic activities and a major highlight for researchers in the field. Participants include stroke researchers at all career stages and with different backgrounds, who convene for plenary lectures and discussions. The workshop was organised in seven scientific sessions focusing on the following topics: (1) acute stroke treatment and endovascular therapy; (2) small vessel disease; (3) opportunities for stroke research in the omics era; (4) vascular cognitive impairment; (5) intracerebral and subarachnoid haemorrhage; (6) alternative treatment concepts and (7) neural circuits, recovery and rehabilitation. All sessions started with a keynote lecture providing an overview on current developments, followed by focused talks on a timely topic with the most recent findings, including unpublished data. In the following, we summarise the key contents of the meeting. The program is provided in the online only Data Supplement. The workshop started with a key note lecture on how to improve the efficiency of clinical trial endpoints in stroke, which was delivered by Craig Anderson (Sydney, Australia) and set the scene for the following discussions.